Vaccine Plus Montanide ISA-51 and Sargramostim in Treating Patients With Stage IV Breast Cancer - Related Studies

Vaccine Plus Montanide ISA-51 and Sargramostim in Treating Patients With Stage IV Breast Cancer

This study is currently recruiting participants.

Study NCT00079157. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Breast Cancer

2	Additional conditions recognized in this trial
		Breast Neoplasms

3	More general conditions related to this trial
		Breast Diseases
		Neoplasms
		Neoplasms by Site
		Skin Diseases

4	Interventions listed in this trial
		incomplete Freund's adjuvant
		sargramostim
		telomerase: 540-548 peptide vaccine

5	Additional drug interventions recognized in this trial
		Freund's Adjuvant

6	More general drug interventions related to this trial
		Adjuvants, Immunologic
		Immunologic Factors
		Pharmacologic Actions
		Physiological Effects of Drugs

7	Sponsors listed in this trial
		University of Pennsylvania
		National Cancer Institute (NCI)